Valley Brook Capital Group’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Valley Brook Capital Group's ALAB Position: Q2 2026 in Review
Valley Brook Capital Group increased its Astera Labs (ALAB) stake by 12% in Q2 2026, buying an estimated $73K and bringing the position to 2,600 shares worth $1.26M. The position accounts for 0.71% of the portfolio, ranked #40.
Valley Brook Capital Group first reported a position in ALAB in Q3 2025 and has held it in 4 quarters since. 991 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Valley Brook Capital Group held 2,600 shares of Astera Labs worth $1.26M as of Q2 2026.
- Valley Brook Capital Group bought 275 Astera Labs shares in Q2 2026, an estimated $73K.
- Astera Labs made up 0.71% of Valley Brook Capital Group's portfolio in Q2 2026, its #40 holding.
- Valley Brook Capital Group first reported a position in Astera Labs in Q3 2025 and has held it in 4 quarters since.
- 991 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.